statistiche ricercatore

Continente	#
NA - Nord America	857
AS - Asia	400
EU - Europa	350
SA - Sud America	59
AF - Africa	5
Continente sconosciuto - Info sul continente non disponibili	2
OC - Oceania	1
Totale	1.674

Nazione	#
US - Stati Uniti d'America	839
GB - Regno Unito	143
SG - Singapore	136
CN - Cina	110
IT - Italia	52
SE - Svezia	51
BR - Brasile	45
VN - Vietnam	39
HK - Hong Kong	34
DE - Germania	28
TR - Turchia	25
UA - Ucraina	17
FR - Francia	15
CA - Canada	14
RU - Federazione Russa	13
FI - Finlandia	12
IN - India	12
BD - Bangladesh	10
ID - Indonesia	9
BG - Bulgaria	8
AR - Argentina	6
KR - Corea	6
IQ - Iraq	4
CO - Colombia	3
AE - Emirati Arabi Uniti	2
BB - Barbados	2
GE - Georgia	2
IE - Irlanda	2
IL - Israele	2
JP - Giappone	2
LT - Lituania	2
MA - Marocco	2
NL - Olanda	2
VE - Venezuela	2
AT - Austria	1
BE - Belgio	1
BO - Bolivia	1
BY - Bielorussia	1
CL - Cile	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
EC - Ecuador	1
ES - Italia	1
EU - Europa	1
HN - Honduras	1
IR - Iran	1
KE - Kenya	1
LB - Libano	1
LK - Sri Lanka	1
MX - Messico	1
MY - Malesia	1
QA - Qatar	1
SA - Arabia Saudita	1
TN - Tunisia	1
TV - Tuvalu	1
TW - Taiwan	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.674

Nome	#
Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache	314
Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache	310
O015. Evaluation of the genetic polymorphism of the α3 (CHRNA3) and α5 (CHRNA5) nicotinic receptor subunits, in patients with cluster headache	275
Sex steroids and HIV-related osteoporosis in men: low circulating estrogens are associated with impaired bone mineral density	201
Sex steroids and HIV-related osteoporosis in men: low circulating estrogens are associated with impaired bone mineral density (BMD)	196
Sex steroids and HIV-related osteoporosis in men: low circulating estrogens are associated with impaired bone mineral density (BMD)	194
Cigarette smoking may sustain the active phase of episodic cluster headache	182
Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial	15
Totale	1.687

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	133	15	19	1	22	4	4	3	7	8	10	21	19
2022/2023	142	12	18	9	21	19	22	4	11	21	1	2	2
2023/2024	95	2	7	8	13	10	17	8	11	0	0	5	14
2024/2025	297	6	5	1	17	64	43	12	19	47	10	32	41
2025/2026	397	41	14	24	38	72	18	49	21	38	38	38	6
2026/2027	13	13	0	0	0	0	0	0	0	0	0	0	0
Totale													1.687